Volume 149, Issue 5, Pages 1245-1251 (May 2016) Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer  Tom van der Hulle, MD, Paul L. den Exter, MD, Pim van den Hoven, MD, Jacobus J. van der Hoeven, MD, PhD, Felix J.M. van der Meer, MD, PhD, Jeroen Eikenboom, MD, PhD, Menno V. Huisman, MD, PhD, Frederikus A. Klok, MD, PhD  CHEST  Volume 149, Issue 5, Pages 1245-1251 (May 2016) DOI: 10.1016/j.chest.2015.10.069 Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 1 Treatment of cancer-associated venous thromboembolism in the total cohort (N = 358) is shown. CHEST 2016 149, 1245-1251DOI: (10.1016/j.chest.2015.10.069) Copyright © 2016 American College of Chest Physicians Terms and Conditions

Figure 2 Shown is the cumulative incidence rate of recurrent VTE in patients who stopped anticoagulation therapy after being cured of cancer (solid line) and after stopping anticoagulation for reasons other than major hemorrhage despite active cancer (dotted line). CHEST 2016 149, 1245-1251DOI: (10.1016/j.chest.2015.10.069) Copyright © 2016 American College of Chest Physicians Terms and Conditions